Dr Marguerite Evans-Galea AM is a scientist, executive and entrepreneur. Dr Evans-Galea is Executive Director of the Industry Mentoring Network in STEM (IMNIS) with the Australian Academy of Technology and Engineering (ATSE), and co-founder & CEO of Women in STEMM Australia.
With a PhD in molecular biology and almost 20 years experience leading international research programs in cell and gene therapy for genetic disease at world-leading organisations in the United States and Australia, Dr Evans-Galea has received numerous awards for her research and leadership. She currently serves on the Australian Sickle Cell Advocacy Board, the ARC Centre for Nanoscale Biophotonics Advisory Board and Chairs the CNBP Nurturing Environment Committee. She is also the Australasian Associate Editor on the Editorial Board with Gene Therapy-Springer Nature.An internationally recognised advocate for women in STEMM, Dr Evans-Galea co-chairs the Women in STEMM Australia Board and served on the Science in Australia Gender Equity Expert Advisory Group. She also serves on the inaugural Ministerial Council for Women’s Equality in Victoria, and is an Ambassador for the Victorian Honour Roll of Women and Scienceworks Museum. Dr Evans-Galea has also represented Australia at the Asia-Pacific Economic Cooperation (APEC) Women in STEMM meetings.A renowned advocate for STEMM research, education and innovation, Dr Evans-Galea has served with advisory groups in State and Federal government, and communicates on a range of science-related topics via social and mainstream media. An independent consultant, speaker, editor and peer reviewer, Dr Evans-Galea is actively engaged across multiple professional sectors in the broader STEMM ecosystem.
Find out more about Marguerite Evans-Galea's experience
Marguerite Evans-Galea's highlights
Marguerite Evans-Galea's selected work
Friedreich's ataxia induced pluripotent stem cell-derived cardiomyocytes display electroph..
An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resverat..
Displaying the 16 most recent scholarly works by Marguerite Evans-Galea.
DEVELOPING CELL AND GENE THERAPY TO TREAT FRIEDREICH ATAXIA
Sze Hwee Ong, Dong C Zhang, Chou H Sim, M Burton, Dean Phelan, Sarah EM Stephenson, Gabrielle R Wilson, Donald F Newgreen, Anthony J Hannan, Paul J Lockhart, Martin B Delatycki, Marguerite V Evans-Galea
Conference Proceedings | 2018 | JOURNAL OF GENE MEDICINE
Friedreich's ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiency
Duncan E Crombie, Claire L Curl, Antonia JA Raaijmakers, Priyadharshini Sivakumaran, Tejal Kulkarni, Raymond CB Wong, Itsunari Minami, Marguerite V Evans-Galea, Shiang Y Lim, Lea Delbridge, Louise A Corben, Mirella Dottori, Norio Nakatsuji, Ian A Trounce, Alex W Hewitt, Martin B Delatycki, Martin F Pera, Alice Pebay
Journal article | 2017 | AGING-US
Compound Heterozygous FXN Mutations and Clinical Outcome in Friedreich Ataxia
Charles A Galea, Aamira Huq, Paul J Lockhart, Geneieve Tai, Louise A Corben, Eppie M Yiu, Lyle C Gurrin, David R Lynch, Sarah Gelbard, Alexandra Durr, Francoise Pousset, Michael Parkinson, Robyn Labrum, Paola Giunti, Susan L Perlman, Martin B Delatycki, Marguerite V Evans-Galea
Journal article | 2016 | Annals of Neurology
An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels
Eppie M Yiu, Geneieve Tai, Roger E Peverill, Katherine J Lee, Kevin D Croft, Trevor A Mori, Barbara Scheiber-Mojdehkar, Brigitte Sturm, Monika Praschberger, Adam P Vogel, Gary Rance, Sarah EM Stephenson, Joseph P Sarsero, Creina Stockley, Chung-Yung J Lee, Andrew Churchyard, Marguerite V Evans-Galea, Monique M Ryan, Paul J Lockhart, Louise A Corben, et al.
Journal article | 2015 | JOURNAL OF NEUROLOGY
HFE p.C282Y Heterozygosity Is Associated With Earlier Disease Onset in Friedreich Ataxia
Martin B Delatycki, Geneieve Tai, Louise Corben, Eppie M Yiu, Marguerite V Evans-Galea, Sarah EM Stephenson, Lyle Gurrin, Katrina J Allen, David Lynch, Paul J Lockhart
Journal article | 2014 | Movement Disorders
Beyond loss of frataxin: the complex molecular pathology of Friedreich ataxia.
Marguerite V Evans-Galea, Paul J Lockhart, Charles A Galea, Anthony J Hannan, Martin B Delatycki
Journal article | 2014 | Discovery Medicine
Friedreich ataxia (FRDA) is a devastating neurodegenerative disease caused by mutations in the frataxin gene (FXN). Frataxin is an..
FXN methylation predicts expression and clinical outcome in Friedreich ataxia
Marguerite V Evans-Galea, Nissa Carrodus, Simone M Rowley, Louise A Corben, Geneieve Tai, Richard Saffery, John C Galati, Nicholas C Wong, Jeffrey M Craig, David R Lynch, Sean R Regner, Alicia FD Brocht, Susan L Perlman, Khalaf O Bushara, Christopher M Gomez, George R Wilmot, Lingli Li, Elizabeth Varley, Martin B Delatycki, Joseph P Sarsero
Journal article | 2012 | Annals of Neurology
Generation of Induced Pluripotent Stem Cell Lines from Friedreich Ataxia Patients
Jun Liu, Paul J Verma, Marguerite V Evans-Galea, Martin B Delatycki, Anna Michalska, Jessie Leung, Duncan Crombie, Joseph P Sarsero, Robert Williamson, Mirella Dottori, Alice Pebay
Journal article | 2011 | Stem Cell Reviews and Reports
Honours, Awards and Fellowships
Member of the Order of Australia
Paediatrics Royal Children'S Hospital
Australasian Gene and Cell Therapy Society
Active Member, International
American Society for Gene and Cell Therapy, USA
Doctor of Philosophy
University of New South Wales
Post Graduate Diploma of Science
The University of Queensland
Bachelor of Science
The University of Queensland
Bachelor of Music
The University of Queensland